Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring

Pediatrics

Volumn 135, Issue 5, 2015, Pages 859-867

  Dhalwani, Nafeesa N ^a   Szatkowski, Lisa ^a   Coleman, Tim ^a   Fiaschi, Linda ^a   Tata, Laila J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH HAZARD; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MEDICAL RECORD; NICOTINE REPLACEMENT THERAPY; PREGNANCY; PRENATAL EXPOSURE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; SMOKING; UNITED KINGDOM; ABNORMALITIES, DRUG-INDUCED; NEWBORN; PREGNANCY COMPLICATIONS; PROCEDURES; SMOKING CESSATION; TOBACCO USE DISORDER;

NICOTINE;

ABNORMALITIES, DRUG-INDUCED; FEMALE; HUMANS; INFANT, NEWBORN; NICOTINE; PREGNANCY; PREGNANCY COMPLICATIONS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84929497544     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-2560     Document Type: Article

References (53)

1. Royal College of Physicians. Passive Smoking and Children-A Report by the Tobacco Advisory Group. London, UKRoyal College of Physicians; 2010
2. Chung KC, Kowalski CP, Kim HM, Buchman SR. Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate. Plast Reconstr Surg. 2000;105(2): 485-491
3. Grewal J, Carmichael SL, Ma C, Lammer EJ, Shaw GM. Maternal periconceptional smoking and alcohol consumption and risk for select congenital anomalies. Birth Defects Res A Clin Mol Teratol. 2008;82(7):519-526
4. Gunnerbeck A, Edstedt Bonamy AK, Wikström AK, Granath F, Wickström R, Cnattingius S. Maternal snuff use and smoking and the risk of oral cleft malformations-a population-based cohort study. PLoS One. 2014;9(1):e84715
5. Honein MA, Rasmussen SA, Reefhuis J, et al. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology. 2007;18(2):226-233
6. Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: A systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011;17(5):589-604
7. Health and Social Care Information Centre. The Infant Feeding Survey 2010: Early Results. York, UK: The NHS Information Centre; 2011
8. Centers for Disease Control and Prevention. Prevalence of smoking during the last 3 months of pregnancy, PRAMS, 2000-2008. Available at: www.cdc. gov/prams/DATA-TobaccoTables. htmtable2. Accessed June 14, 2013
9. Scollo M, Winstanlet M. Tobacco in Australia: Facts and Issues. Melbourne, Australia: Cancer Council Victoria; 2012
10. Action on Smoking and Health. Nicotine Replacement Therapy-Guidance for Health Professionals on Changes in the Licensing Arrangements for Nicotine Replacement Therapy. London, UKAction on Smoking and Health; 2005
11. Dhalwani N, Tata L, Coleman T, Szatkowski L. Prescribing of nicotine replacement therapy in and around pregnancy in the UK-a populationbased study using primary care data. J Epidemiol Community Health. 2013;67 (suppl 1):A7
12. Morales-Suárez-Varela MM, Bille C, Christensen K, Olsen J. Smoking habits, nicotine use, and congenital malformations. Obstet Gynecol. 2006; 107(1):51-57
13. Coleman T, Cooper S, Thornton JG, et al; Smoking, Nicotine, and Pregnancy (SNAP) Trial Team. A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med. 2012;366(9): 808-818
14. Berlin I, Grangé G, Jacob N, Tanguy ML. Nicotine patches in pregnant smokers: randomized, placebo controlled, multicentre trial of efficacy. BMJ. 2014; 348:g1622
15. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007; 16(4):393-401
16. Szatkowski L, Lewis S, McNeill A, Huang Y, Coleman T. Can data from primary care medical records be used to monitor national smoking prevalence? J Epidemiol Community Health. 2012;66(9): 791-795
17. Langley TE, Szatkowski LC, Wythe S, Lewis SA. Can primary care data be used to monitor regional smoking prevalence? An analysis of The Health Improvement Network primary care data. BMC Public Health. 2011;11:773
18. Tata LJ, Hubbard RB, McKeever TM, et al. Fertility rates in women with asthma, eczema, and hay fever: A general population-based cohort study. Am J Epidemiol. 2007;165(9):1023-1030
19. CSD Medical Research UK. THIN Data Guide for Researchers. London, UK: CSD Medical Research UK; 2011
20. NHS Connecting for Health. Read Codes. Available at: www.connectingforhealth. nhs.uk/systemsandservices/data/uktc/readcodes. Accessed January 15, 2012
21. World Health Organization. ICD-10 version. Available at: http://apps.who.int/classifications/icd10/browse/2010/en. Accessed June 15, 2013
22. European Surveillance of Congenital Anomalies. EUROCAT Guide 1.3 and reference documents-instructions for the registration and surveillance of congenital anomalies. Available at: www. eurocat-network.eu/content/EUROCATGuide-1.3.pdf. Accessed June 13, 2013
23. Sokal R, Fleming KM, Tata LJ. Potential of general practice data for congenital anomaly research: comparison with registry data in the United Kingdom. Birth Defects Res A Clin Mol Teratol. 2013;97(8):546-553
24. Joint Formulary Committee. British National Formulary (BNF). 62nd ed. London, UK: BMJ Group and Pharmaceutical Press; 2011
25. Yudkin P, Hey K, Roberts S, Welch S, Murphy M, Walton R. Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ. 2003;327(7405): 28-29
26. Townsend P, Phillimore P, Beattie A. Health and Deprivation: Inequality and the North. London, UK: Croom Helm; 1988
27. Caton AR, Bell EM, Druschel CM, et al; National Birth Defects Prevention Study. Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A Clin Mol Teratol. 2008;82(1):34-40
28. Åberg A, Westbom L, Källén B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev. 2001;61(2):85-95
29. Bar-Oz B, Einarson T, Einarson A, et al. Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin Ther. 2007;29(5):918-926
30. Blomberg MI, Källén B. Maternal obesity and morbid obesity: the risk for birth defects in the offspring. Birth Defects Res A Clin Mol Teratol. 2010;88(1):35-40
31. Tata LJ, Lewis SA, McKeever TM, et al. Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: A UK population-based study. Thorax. 2008;63(11):981-987
32. Nazer H J, Cifuentes O L, Aguila R A, et al. The association between maternal age and congenital malformations in Spanish. Rev Med Chil. 2007;135(11): 1463-1469
33. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension. 2001;37(2): 187-193
34. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the genetics and environment of asthma. Eur Respir J. 2000;15(3):470-477
35. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87(4): 801-809
36. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol. 2001;30(3): 540-546
37. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284(20):2606-2610
38. StataCorp. Generalized estimating equations: xtgee. Available at: www.stata. com/capabilities/generalized-estimatingequations/. Accessed May 30, 2012
39. Sokal R, Fleming K, Tata LJ. The potential of general practise data for congenital anomaly research. Arch Dis Child Fetal Neonatal Ed. 2013;98(suppl 1):A87
40. Charlton RA, Weil JG, Cunnington MC, de Vries CS. Identifying major congenital malformations in the UK General Practice Research Database (GPRD): A study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD. Drug Saf. 2010;33(9):741-750
41. Wurst KE, Ephross SA, Loehr J, Clark DW, Guess HA. The utility of the general practice research database to examine selected congenital heart defects: A validation study. Pharmacoepidemiol Drug Saf. 2007;16(8):867-877
42. Lassen TH, Madsen M, Skovgaard LT, Strandberg-Larsen K, Olsen J, Andersen A-MN. Maternal use of nicotine replacement therapy during pregnancy and offspring birthweight: A study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol. 2010;24(3): 272-281
43. National Audit Office, Department of Health. Maternity Services in England. London, UK: The Stationery Office; 2013
44. Health and Social Care Information Centre. NHS Stop Smoking Services: England, April 2012 to December 2012 (Q3-Quarterly report). Leeds, UK: Health and Social Care Information Centre; 2013
45. Fahy SJ, Cooper S, Coleman T, Naughton F, Bauld L. Provision of smoking cessation support for pregnant women in England: Results from an online survey of NHS stop smoking services for pregnant women. BMC Health Services Research. 2014;14(1):107
46. Afolabi AO. Self Medication, Drug Dependency and Self-Managed Health Care-A Review, Public Health-Social and Behavioral Health.2012. Croatia: InTech Open Access Publisher; 2013
47. Choices NHS. Are pregnant women entitled to free NHS prescriptions? Available at: www.nhs.uk/chq/Pages/941. aspx?CategoryID68&SubCategoryID 161close. Accessed October 16, 2013
48. Wilson A, Manku-Scott T, Shepherd D, Jones B. A comparison of individual and population smoking data from a postal survey and general practice records. Br J Gen Pract. 2000;50(455):465-468
49. Alberg AJ, Patnaik JL, May JW, et al. Nicotine replacement therapy use among a cohort of smokers. J Addict Dis. 2005; 24(1):101-113
50. Shiffman S, Di Marino ME, Sweeney CT. Characteristics of selectors of nicotine replacement therapy. Tob Control. 2005; 14(5):346-355
51. Blais L, Kettani FZ, Elftouh N, Forget A. Effect of maternal asthma on the risk of specific congenital malformations: A population-based cohort study. Birth Defects Res A Clin Mol Teratol. 2010; 88(4):216-222
52. Ban L. Maternal Perinatal Mental Illnesses and Adverse Pregnancy Outcomes: Population-Based Studies Using Data From United Kingdom Primary Care. Nottingham, UK: Division of Epidemiology and Public Health, University of Nottingham; 2012
53. Sekhon HS, Jia Y, Raab R, et al. Prenatal nicotine increases pulmonary a7 nicotinic receptor expression and alters fetal lung development in monkeys. J Clin Invest. 1999;103(5):637-647